ERBB2 and breast cancer: In this study, we identified 3145 distant relapse–free survival (DRFS) associated genes in 310 patients with HER-2 negative breast cancer receiving taxane and anthracycline-based chemotherapy in the GSE25055 dataset using univariate survival analysis.